# Capillary Technologies India share price today (Capillary Technologies India Ltd, NSE: CAPILLARY) > Capillary Technologies India share price today: ₹510.10 at the NSE close on 4 November 2026, down 15.9% in a year. Capillary Technologies India (NSE: CAPILLARY) is worth ₹4,056 crore, trades at a P/E of 79.2 and has closed between ₹448.95 and ₹732.15 over the past 52 weeks. > Capillary Technologies India Ltd's earnings have grown faster than its share price. Earnings per share grew +264.6% in a year while the price moved −15.9%. CAPILLARY · IT - Software · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/capillary-technologies-india-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Price: ₹510.10 (−15.9% in a year) - P/E: 79.2× (lower than 90% of the last 11 months) - Revenue (Jun 2026): ₹257 Cr (+42.7% on a year ago) - Profit (Jun 2026): −₹9.6 Cr (−1,373.3% on a year ago) - Operating margin: 15.7% (+5.8 points on a year ago) - ROCE: 3%, FY26 - ROIC: 4.7%, against a 12.0% cost of capital: −7.3 points - Profit that came in as cash: 160%, last 2 years The main question: yearly earnings per share moved +264.6% while the share price moved −15.9%. ## What is the Capillary Technologies India share price today? Capillary Technologies India Ltd's share price was ₹510.10 at the close on 4 November 2026. It has been falling for 36 weeks. That is 5.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹449 and ₹732, and at that close it sat 22% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running. Over the last 1 year the share price moved −16% while the NIFTY 500 moved −9%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Capillary Technologies India this quarter? Three changes stood out: promoters cut their stake for 3 quarters in a row, indian funds and insurers (DIIs) raised their stake for 3 quarters in a row and foreign funds (FIIs) cut their stake for 3 quarters in a row. 1. Promoters cut their stake for 3 quarters in a row From 52.3% to 47.2% of the company by the September 2026 quarter. 2. Indian funds and insurers (DIIs) raised their stake for 3 quarters in a row From 17.8% to 21.9% of the company by the September 2026 quarter. 3. Foreign funds (FIIs) cut their stake for 3 quarters in a row From 3.9% to 2.6% of the company by the September 2026 quarter. ## What are Capillary Technologies India's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Capillary Technologies India reported revenue of ₹257 crore, up 42.7% from ₹180 crore a year earlier, and a loss of ₹9.55 crore, down 1,373.3% from ₹0.75 crore. ### Capillary Technologies India results: April to June 2026 against a year earlier | Measure | April to June 2026 | April to June 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹257 crore | ₹180 crore | +42.7% | | Profit | loss of ₹9.55 crore | ₹0.75 crore | −1,373.3% | | Earnings per share | ₹−1.20 | ₹0.10 | −1,300.0% | | Operating margin | 15.7% | 9.9% | +5.8 points | The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Capillary Technologies India's management discussed these results on a call held on 4 August 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.) ## What is the Capillary Technologies India share price history? Capillary Technologies India closed at ₹510.10 on 4 November 2026, down 15.9% from ₹606.50 a year earlier (21 November 2025). Its highest weekly close since November 2025 was ₹719.35 on 12 December 2025. ### Capillary Technologies India share price: then and now | When | Close | Change to 4 Nov 2026 | | --- | --- | --- | | 1 week ago · 30 Oct 2026 | ₹502.55 | +1.5% | | 1 month ago · 1 Oct 2026 | ₹554.70 | −8.0% | | 6 months ago · 8 May 2026 | ₹572.90 | −11.0% | | 1 year ago · 21 Nov 2025 | ₹606.50 | −15.9% | | Earliest weekly close in our records · 21 Nov 2025 | ₹606.50 | −15.9% | | Highest weekly close since November 2025 · 12 Dec 2025 | ₹719.35 | −29.1% | | Lowest weekly close since November 2025 · 11 Sep 2026 | ₹461.95 | +10.4% | Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (54 weekly closes from 21 November 2025 to 4 November 2026.) ## What is the latest news on Capillary Technologies India? 4 Nov 2026: Capillary Technologies India closed at ₹510.10, up 1.5% on the week and down 8.0% on the month. 4 Aug 2026: Capillary Technologies India held its results call for April to June 2026. Management guided: FY27 revenue above ₹1,065 crore. ### Earlier - Results for April to June 2026: Revenue up 42.7% and profit down 1,373.3% on a year earlier. ## What dividend does Capillary Technologies India pay? Capillary Technologies India has paid no dividend on the NSE since its first NSE close in our records (21 November 2025), the start of the period we checked. No. Capillary Technologies India Ltd paid out 0% of its profit as dividends in each of its last 6 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 5 November 2026.) ## What did Capillary Technologies India management say on the latest results call? On the call for April to June 2026, held on 4 August 2026, Capillary Technologies India's management guided: FY27 revenue above ₹1,065 crore. > “My expectation is that the journey will be from approximately breakeven today to approximately 15% margin in a year. Over the following year, we will reach a 35-40% margin. - Aneesh Reddy Boddu” > Founder, Managing Director & CEO, on the call for April to June 2026 ### What management guided - FY27 operating profit above ₹172 crore. - FY27 organic revenue growth approximately 17% and consolidated growth approximately 23% including currency; new ACV at least 30-40% higher on a year earlier. - AiRA to reach 5-10% of revenue this year. - SessionM payback possibly within FY27; server-cost savings of $6-8 million over 3-4 quarters; operating margin approximately 15% in one year and 35-40% the following year. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/47076/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 4 August 2026.) ## What to watch in Capillary Technologies India's next results? When Capillary Technologies India reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Kognitiv's first customer migration in September - check AI-tool validation and subsequent rollout pace. - What to check (from the call) - Kognitiv's first customer migration in September - check AI-tool validation and subsequent rollout pace. - SessionM server-cost program - check whether margin progression continues before customer migrations begin. - AiRA live deployments converting into paying contracts - check revenue contribution and any cannibalization. - Cyber-fraud insurance process - check confirmed recovery amount and timing. ## Which stock lists is Capillary Technologies India on? Capillary Technologies India is on one of our India lists: IT stocks. [IT stocks Market value (₹ crore): 4060.093523032534](https://www.sectoralpha.in/sectors/it-stocks-india) ## Is Capillary Technologies India profitable? Capillary Technologies India Ltd posted a net loss of ₹9.6 Cr in the Jun 2026 quarter. Full-year FY26 profit was ₹52.0 Cr. That loss is 3.7% of the quarter's revenue. The same quarter a year earlier earned ₹0.8 Cr. 1 of the last 8 reported quarters were loss-making. Jun 2026 profit was −₹9.6 Cr, −1,373.3% on a year earlier. For the full year, FY26 profit was ₹52.0 Cr (+300.0% on the year before). Why profit moved: revenue changed +42.7% on a year earlier and the margin moved +5.8 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed −351.6% and revenue +28.1%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Capillary Technologies India make, and is it growing? Capillary Technologies India Ltd reported ₹257 Cr of revenue in the Jun 2026 quarter, +42.7% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 5 years it has grown 33.9% a year on average. The last full year, FY26, came in at ₹735 Cr. The last four reported quarters add to ₹811 Cr. FY26 revenue was ₹735 Cr, +22.9% on the year before. Recent pace: the last four quarters grew +28.1% on average, against 33.9% a year over the longer run, so this year is growing slower than its own long-run rate. ## How much of every ₹100 of sales does Capillary Technologies India keep? Capillary Technologies India Ltd's operating margin was 15.7% in the Jun 2026 quarter, 5.8 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 6 years it has been between −23.0% and 13.0%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +5.8 percentage points on the year while gross margin changed +0.0 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead. ## Is Capillary Technologies India's profit turning into cash? Over the last 2 years, 160% of Capillary Technologies India Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹150 Cr of operating cash against ₹52.0 Cr of profit. After ₹234 Cr of spending on assets, free cash was −₹84.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 160% of profit came in as cash: the cash cycle got 27 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: the bigger use of cash is spending on new assets, at 2.3× depreciation over three years. The next section checks what that spending is building. ## Where does Capillary Technologies India's cash go? Capillary Technologies India Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 90 days in FY26, down from 117 days in FY21. It spent ₹442 Cr on assets over the last 3 years. At FY26 sales of ₹735 Cr, each day of that cycle ties up about ₹2.0 Cr, so roughly ₹181 Cr is tied up in the business at any time. Spending on assets: ₹442 Cr over the last 3 years, against ₹191 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Capillary Technologies India's P/E ratio, and how does it compare with its own history? Capillary Technologies India Ltd's P/E is 79.2×, near the low end of its own history: it has been lower only 10% of the time. Its usual P/E (the middle reading) is 732.0×, over 11 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹5.31. Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks. Why the multiple is where it is: over the past year earnings per share moved +264.6% while the price moved −15.9%. Earnings did better than the price, which pulled the multiple down within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Capillary Technologies India business getting better or worse? Capillary Technologies India Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Capillary Technologies India earn on its capital? Capillary Technologies India Ltd earned a ROCE of 3% in FY26. That is up from a low of −68% in FY22. Its return on capital used (ROIC) is 7.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 7.1% net margin and 0.57× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 7.1% net margin × 0.57× asset turnover × 1.27× leverage (assets divided by equity) ≈ 5.1% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 4.7% − 12.0% = −7.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Capillary Technologies India have too much debt? Capillary Technologies India Ltd has total debt of ₹54.0 Cr against shareholder equity of ₹1,023 Cr as of Jun 2026, so its debt is 0.05× its equity, which is very little. Year by year, that ratio went from 0.19 in FY25 to 0.05 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Capillary Technologies India shareholding pattern? No group of Capillary Technologies India Ltd's owners changed its stake by a full percentage point over the last 4 quarters. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. ## How far is Capillary Technologies India from balance-sheet trouble? For Capillary Technologies India Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Capillary Technologies India rank in its industry? 52.6 out of 100, rank 30 of 69 in IT - Software, with 59% of the evidence available. Capillary Technologies India Ltd scores 52.6 out of 100 against the 69 companies it is compared with in IT - Software, ranking 30. Some evidence is missing, so the score is pulled toward the middle on purpose. The three scored parts add up to the total exactly: 34.2 + 7.4 + 11 = 52.6 (no relative-strength reading this week; its 20 points are shared across the other three). This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Capillary Technologies India compared with? Capillary Technologies India ranks 30 of 69 IT - Software companies on the 4-Factor Sector Score, with 52.6 out of 100. 1. [Coforge Ltd](https://www.sectoralpha.in/stocks/coforge-ltd) COFORGE · leader · Most evidence points up · 100% evidence 69.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 41.5% · Profit 56.3% · Operating margin change 1 points · 100% evidence Capital efficiency 16.4/25 · ROCE 23.5% · Operating margin 20% · 100% evidence Valuation 11.3/20 · P/E 41.7× · PEG 0.57 · 100% evidence Relative strength 18.5/20 · Lead over its industry 24.5% · Lead over NIFTY 500 35.5% · 1 year 15% · 100% evidence · 12 of 12 weeks ahead Exact sum: 23.4 + 16.4 + 11.3 + 18.5 = 69.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Expleo Solutions Ltd](https://www.sectoralpha.in/stocks/expleo-solutions-ltd) EXPLEOSOL · breaking out · Most evidence points up · 81% evidence 68.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.6/35 · Revenue 10.4% · Profit 39.4% · Operating margin change 4 points · 88% evidence Capital efficiency 15.4/25 · ROCE 24.2% · Operating margin 15% · 100% evidence Valuation 18.7/20 · P/E 8.5× · PEG 0.33 · 100% evidence Relative strength 9.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -2.7% · 1 year -20.7% · 25% evidence · 8 of 12 weeks ahead Exact sum: 24.6 + 15.4 + 18.7 + 9.6 = 68.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Cigniti Technologies Ltd](https://www.sectoralpha.in/stocks/cigniti-technologies-ltd) CIGNITITEC · Too little evidence to rank firmly · 55% evidence 68.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.8/43.75 · Revenue 14% · Profit 96.1% · Operating margin change 2 points · 47% evidence Capital efficiency 20.8/31.25 · ROCE 34.1% · Operating margin 18% · 75% evidence Valuation 19.5/25 · P/E 11.4× · PEG 0.74 · 100% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 27.8 + 20.8 + 19.5 = 68.1 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 4. [Metalic Technoforge Ltd](https://www.sectoralpha.in/stocks/metalic-technoforge-ltd) META · turning · Too little evidence to rank firmly · 51% evidence 67.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.8/43.75 · Revenue 100% · Profit 100% · Operating margin change 0 points · 83% evidence Capital efficiency 20.2/31.25 · ROCE 44% · Operating margin 11% · 76% evidence Valuation 14.3/25 · P/E 6.6× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 32.8 + 20.2 + 14.3 = 67.3 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [Sahana Systems Ltd](https://www.sectoralpha.in/stocks/sahana-systems-ltd) SAHANA · leader · Too little evidence to rank firmly · 54% evidence 66.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.4/35 · Revenue 100% · Profit 100% · Operating margin change -3 points · 27% evidence Capital efficiency 18.4/25 · ROCE 39.8% · Operating margin 29% · 57% evidence Valuation 12.0/20 · P/E 14.5× · PEG n/a · 50% evidence Relative strength 17.2/20 · Lead over its industry 12.3% · Lead over NIFTY 500 22.7% · 1 year 5.7% · 100% evidence · 12 of 12 weeks ahead Exact sum: 18.4 + 18.4 + 12 + 17.2 = 66 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 6. [Silver Touch Technologies Ltd](https://www.sectoralpha.in/stocks/silver-touch-technologies-ltd) SILVERTUC · quiet · Most evidence points up · 100% evidence 65.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.9/35 · Revenue 21.7% · Profit 88% · Operating margin change 5 points · 100% evidence Capital efficiency 21.3/25 · ROCE 29.8% · Operating margin 21% · 100% evidence Valuation 11.2/20 · P/E 31.6× · PEG 1.11 · 100% evidence Relative strength 3.0/20 · Lead over its industry -21.7% · Lead over NIFTY 500 -13.9% · 1 year 52.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 29.9 + 21.3 + 11.2 + 3 = 65.4 · What this means: Earnings are strong; relative strength in its sector is -21.7% and the one-year return is 52.9%. 7. [NINtec Systems Ltd](https://www.sectoralpha.in/stocks/nintec-systems-ltd) NINSYS · turning · Most evidence points up · 93% evidence 65.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.2/35 · Revenue 18.8% · Profit 23.3% · Operating margin change 2 points · 100% evidence Capital efficiency 22.4/25 · ROCE 54% · Operating margin 27% · 100% evidence Valuation 6.6/20 · P/E 48.1× · PEG 2.08 · 65% evidence Relative strength 18.2/20 · Lead over its industry 57.5% · Lead over NIFTY 500 70.4% · 1 year 113.7% · 100% evidence · 4 of 12 weeks ahead Exact sum: 18.2 + 22.4 + 6.6 + 18.2 = 65.4 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 8. [Unified Data- Tech Solutions Ltd](https://www.sectoralpha.in/stocks/unified-data-tech-solutions-ltd) breaking out · Too little evidence to rank firmly · 56% evidence 63.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.0/35 · Revenue n/a · Profit n/a · Operating margin change 2 points · 26% evidence Capital efficiency 18.3/25 · ROCE 34.1% · Operating margin 15% · 95% evidence Valuation 10.2/20 · P/E 17.3× · PEG n/a · 15% evidence Relative strength 17.8/20 · Lead over its industry 11.5% · Lead over NIFTY 500 22% · 1 year -7.6% · 100% evidence · 8 of 12 weeks ahead Exact sum: 17 + 18.3 + 10.2 + 17.8 = 63.3 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 9. [ASM Technologies Ltd](https://www.sectoralpha.in/stocks/asm-technologies-ltd) leader · Evidence leans up · 61% evidence 63.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.1/35 · Revenue 67.8% · Profit 89.5% · Operating margin change 2 points · 83% evidence Capital efficiency 15.9/25 · ROCE 27% · Operating margin 23% · 95% evidence Valuation 8.7/20 · P/E 124× · PEG n/a · 15% evidence Relative strength 12.3/20 · Lead over its industry n/a · Lead over NIFTY 500 66.2% · 1 year 78.6% · 25% evidence · 12 of 12 weeks ahead Exact sum: 26.1 + 15.9 + 8.7 + 12.3 = 63 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Tanla Platforms Ltd](https://www.sectoralpha.in/stocks/tanla-platforms-ltd) TANLA · turning · Evidence leans up · 85% evidence 62.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.7/35 · Revenue 17.7% · Profit 15.4% · Operating margin change 0 points · 100% evidence Capital efficiency 18.3/25 · ROCE 26.3% · Operating margin 16% · 100% evidence Valuation 14.0/20 · P/E 15× · PEG 1.07 · 100% evidence Relative strength 11.7/20 · Lead over its industry n/a · Lead over NIFTY 500 26.7% · 1 year 2.8% · 25% evidence · 3 of 12 weeks ahead Exact sum: 18.7 + 18.3 + 14 + 11.7 = 62.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [String Metaverse Ltd](https://www.sectoralpha.in/stocks/string-metaverse-ltd) breaking out · Evidence leans up · 83% evidence 62.5 out of 100 Growth Capital Valuation Relative 12. [Tech Mahindra Ltd](https://www.sectoralpha.in/stocks/tech-mahindra-ltd) TECHM · leader · Evidence leans up · 85% evidence 62.1 out of 100 Growth Capital Valuation Relative 13. [Infosys Ltd](https://www.sectoralpha.in/stocks/infosys-ltd) INFY · breaking out · Evidence leans up · 82% evidence 61.7 out of 100 Growth Capital Valuation Relative 14. [InfoBeans Technologies Ltd](https://www.sectoralpha.in/stocks/infobeans-technologies-ltd) INFOBEAN · quiet · Evidence leans up · 100% evidence 61.6 out of 100 Growth Capital Valuation Relative 15. [Zensar Technologies Ltd](https://www.sectoralpha.in/stocks/zensar-technologies-ltd) ZENSARTECH · turning · Evidence leans up · 100% evidence 61.6 out of 100 Growth Capital Valuation Relative 16. [Tata Consultancy Services Ltd](https://www.sectoralpha.in/stocks/tata-consultancy-services-ltd) TCS · breaking out · Evidence leans up · 100% evidence 60.9 out of 100 Growth Capital Valuation Relative 17. [Sasken Technologies Ltd](https://www.sectoralpha.in/stocks/sasken-technologies-ltd) SASKEN · turning · Evidence leans up · 100% evidence 60.8 out of 100 Growth Capital Valuation Relative 18. [Birlasoft Ltd](https://www.sectoralpha.in/stocks/birlasoft-ltd) BSOFT · breaking out · Evidence leans up · 100% evidence 59.5 out of 100 Growth Capital Valuation Relative 19. [Seshaasai Technologies Ltd](https://www.sectoralpha.in/stocks/seshaasai-technologies-ltd) STYL · quiet · Evidence leans up · 68% evidence 59.5 out of 100 Growth Capital Valuation Relative 20. [Xchanging Solutions Ltd](https://www.sectoralpha.in/stocks/xchanging-solutions-ltd) XCHANGING · quiet · Evidence leans up · 85% evidence 59.1 out of 100 Growth Capital Valuation Relative 21. [RNIT AI Solutions Ltd](https://www.sectoralpha.in/stocks/rnit-ai-solutions-ltd) AUTOPALIND · breaking out · Evidence leans up · 69% evidence 59.1 out of 100 Growth Capital Valuation Relative 22. [Danlaw Technologies India Ltd](https://www.sectoralpha.in/stocks/danlaw-technologies-india-ltd) breaking out · Evidence leans up · 68% evidence 58.8 out of 100 Growth Capital Valuation Relative 23. [Softtech Engineers Ltd](https://www.sectoralpha.in/stocks/softtech-engineers-ltd) SOFTTECH · breaking out · Evidence leans up · 79% evidence 58.3 out of 100 Growth Capital Valuation Relative 24. [R Systems International Ltd](https://www.sectoralpha.in/stocks/r-systems-international-ltd) RSYSTEMS · losing its lead · Evidence leans up · 96% evidence 57.0 out of 100 Growth Capital Valuation Relative 25. [HCL Technologies Ltd](https://www.sectoralpha.in/stocks/hcl-technologies-ltd) HCLTECH · leader · Evidence leans up · 82% evidence 56.7 out of 100 Growth Capital Valuation Relative 26. [Datamatics Global Services Ltd](https://www.sectoralpha.in/stocks/datamatics-global-services-ltd) DATAMATICS · quiet · Evidence leans up · 81% evidence 55.8 out of 100 Growth Capital Valuation Relative 27. [Wipro Ltd](https://www.sectoralpha.in/stocks/wipro-ltd) WIPRO · turning · Evidence leans up · 100% evidence 55.4 out of 100 Growth Capital Valuation Relative 28. [Subex Ltd](https://www.sectoralpha.in/stocks/subex-ltd) SUBEXLTD · breaking out · Evidence leans up · 64% evidence 55.4 out of 100 Growth Capital Valuation Relative 29. [Ksolves India Ltd](https://www.sectoralpha.in/stocks/ksolves-india-ltd) KSOLVES · quiet · Evidence leans up · 100% evidence 52.8 out of 100 Growth Capital Valuation Relative 30. Capillary Technologies India Ltd this page CAPILLARY · breaking out · Too little evidence to rank firmly · 59% evidence 52.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 34.2/43.75 · Revenue 27.8% · Profit 135.8% · Operating margin change 5.8 points · 88% evidence Capital efficiency 7.4/31.25 · ROCE 3.4% · Operating margin 15.7% · 100% evidence Valuation 11.0/25 · P/E 78.1× · PEG n/a · 15% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 34.2 + 7.4 + 11 = 52.6 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 31. [LTM Ltd](https://www.sectoralpha.in/stocks/ltm-ltd) LTM · losing its lead · Evidence leans up · 100% evidence 51.1 out of 100 Growth Capital Valuation Relative 32. [TechNVision Ventures Ltd](https://www.sectoralpha.in/stocks/technvision-ventures-ltd) TECHNVISN · quiet · Evidence leans up · 64% evidence 51.1 out of 100 Growth Capital Valuation Relative 33. [Saksoft Ltd](https://www.sectoralpha.in/stocks/saksoft-ltd) SAKSOFT · basing · Evidence leans up · 96% evidence 50.9 out of 100 Growth Capital Valuation Relative 34. [BLS E-Services Ltd](https://www.sectoralpha.in/stocks/bls-e-services-ltd) BLSE · leader · Evidence leans up · 78% evidence 50.5 out of 100 Growth Capital Valuation Relative 35. [Mphasis Ltd](https://www.sectoralpha.in/stocks/mphasis-ltd) MPHASIS · breaking out · Evidence leans up · 81% evidence 50.3 out of 100 Growth Capital Valuation Relative 36. [Excelsoft Technologies Ltd](https://www.sectoralpha.in/stocks/excelsoft-technologies-ltd) EXCELSOFT · breaking out · Too little evidence to rank firmly · 59% evidence 50.3 out of 100 Growth Capital Valuation Relative 37. [Blue Cloud Softech Solutions Ltd](https://www.sectoralpha.in/stocks/blue-cloud-softech-solutions-ltd) BLUECLOUDS · turning · Evidence leans down · 64% evidence 49.9 out of 100 Growth Capital Valuation Relative 38. [ACS Technologies Ltd](https://www.sectoralpha.in/stocks/acs-technologies-ltd) ACSTECH · Evidence leans down · 74% evidence 49.5 out of 100 Growth Capital Valuation Relative 39. [Magellanic Cloud Ltd](https://www.sectoralpha.in/stocks/magellanic-cloud-ltd) MCLOUD · basing · Evidence leans down · 81% evidence 49.2 out of 100 Growth Capital Valuation Relative 40. [Dynacons Systems & Solutions Ltd](https://www.sectoralpha.in/stocks/dynacons-systems-solutions-ltd) DSSL · quiet · Evidence leans down · 96% evidence 48.5 out of 100 Growth Capital Valuation Relative 41. [IZMO Ltd](https://www.sectoralpha.in/stocks/izmo-ltd) IZMO · quiet · Evidence leans down · 81% evidence 48.0 out of 100 Growth Capital Valuation Relative 42. [Mastek Ltd](https://www.sectoralpha.in/stocks/mastek-ltd) MASTEK · quiet · Evidence leans down · 100% evidence 47.1 out of 100 Growth Capital Valuation Relative 43. [Sonata Software Ltd](https://www.sectoralpha.in/stocks/sonata-software-ltd) SONATSOFTW · quiet · Evidence leans down · 96% evidence 46.9 out of 100 Growth Capital Valuation Relative 44. [AvenuesAI Ltd](https://www.sectoralpha.in/stocks/avenuesai-ltd) CCAVENUE · quiet · Evidence leans down · 89% evidence 44.8 out of 100 Growth Capital Valuation Relative 45. [Unicommerce eSolutions Ltd](https://www.sectoralpha.in/stocks/unicommerce-esolutions-ltd) UNIECOM · turning · Evidence leans down · 78% evidence 44.6 out of 100 Growth Capital Valuation Relative 46. [Allied Digital Services Ltd](https://www.sectoralpha.in/stocks/allied-digital-services-ltd) ADSL · basing · Evidence leans down · 74% evidence 42.1 out of 100 Growth Capital Valuation Relative 47. [Hexaware Technologies Ltd](https://www.sectoralpha.in/stocks/hexaware-technologies-ltd) HEXT · basing · Evidence leans down · 85% evidence 42.0 out of 100 Growth Capital Valuation Relative 48. [Hypersoft Technologies Ltd](https://www.sectoralpha.in/stocks/hypersoft-technologies-ltd) quiet · Evidence leans down · 80% evidence 40.9 out of 100 Growth Capital Valuation Relative 49. [Kellton Tech Solutions Ltd](https://www.sectoralpha.in/stocks/kellton-tech-solutions-ltd) KELLTONTEC · quiet · Evidence leans down · 96% evidence 38.9 out of 100 Growth Capital Valuation Relative 50. [3i Infotech Ltd](https://www.sectoralpha.in/stocks/3i-infotech-ltd) 3IINFOLTD · Too little evidence to rank firmly · 58% evidence 38.9 out of 100 Growth Capital Valuation Relative 51. [Innovana Thinklabs Ltd](https://www.sectoralpha.in/stocks/innovana-thinklabs-ltd) INNOVANA · basing · Evidence leans down · 81% evidence 37.6 out of 100 Growth Capital Valuation Relative 52. [Mindteck (India) Ltd](https://www.sectoralpha.in/stocks/mindteck-indialtd) MINDTECK · Most evidence points down · 76% evidence 32.8 out of 100 Growth Capital Valuation Relative 53. [Aurionpro Solutions Ltd](https://www.sectoralpha.in/stocks/aurionpro-solutions-ltd) AURIONPRO · basing · Most evidence points down · 93% evidence 29.7 out of 100 Growth Capital Valuation Relative 54. [Moschip Technologies Ltd](https://www.sectoralpha.in/stocks/moschip-technologies-ltd) MOSCHIP · quiet · Most evidence points down · 65% evidence 26.1 out of 100 Growth Capital Valuation Relative 55. [Quick Heal Technologies Ltd](https://www.sectoralpha.in/stocks/quick-heal-technologies-ltd) QUICKHEAL · turning · Most evidence points down · 80% evidence 22.9 out of 100 Growth Capital Valuation Relative 56. Orient Technologies Ltd ORIENTTECH · quiet · Most evidence points down · 76% evidence 21.2 out of 100 Growth Capital Valuation Relative 57. [Covance Softsol Ltd](https://www.sectoralpha.in/stocks/covance-softsol-ltd) Too little evidence to rank firmly · 31% evidence 62.9 out of 100 Growth Capital Valuation Relative 58. [Exato Technologies Ltd](https://www.sectoralpha.in/stocks/exato-technologies-ltd) losing its lead · Too little evidence to rank firmly · 43% evidence 59.2 out of 100 Growth Capital Valuation Relative 59. [TAC Infosec Ltd](https://www.sectoralpha.in/stocks/tac-infosec-ltd) TAC · quiet · Too little evidence to rank firmly · 48% evidence 58.5 out of 100 Growth Capital Valuation Relative 60. [Veefin Solutions Ltd](https://www.sectoralpha.in/stocks/veefin-solutions-ltd) VEEFIN · basing · Too little evidence to rank firmly · 43% evidence 54.2 out of 100 Growth Capital Valuation Relative 61. [Kody Technolab Ltd](https://www.sectoralpha.in/stocks/kody-technolab-ltd) KODYTECH · leader · Too little evidence to rank firmly · 35% evidence 53.5 out of 100 Growth Capital Valuation Relative 62. [Optivalue Tek Consulting Ltd](https://www.sectoralpha.in/stocks/optivalue-tek-consulting-ltd) OPTIVALUE · Too little evidence to rank firmly · 32% evidence 51.4 out of 100 Growth Capital Valuation Relative 63. [Workmates Core2cloud Solution Ltd](https://www.sectoralpha.in/stocks/workmates-core2cloud-solution-ltd) Too little evidence to rank firmly · 26% evidence 51.3 out of 100 Growth Capital Valuation Relative 64. [Trident Techlabs Ltd](https://www.sectoralpha.in/stocks/trident-techlabs-ltd) TECHLABS · Too little evidence to rank firmly · 27% evidence 47.5 out of 100 Growth Capital Valuation Relative 65. [ERP Soft Systems Ltd](https://www.sectoralpha.in/stocks/erp-soft-systems-ltd) Too little evidence to rank firmly · 36% evidence 46.7 out of 100 Growth Capital Valuation Relative 66. [Sancode Technologies Ltd](https://www.sectoralpha.in/stocks/sancode-technologies-ltd) Too little evidence to rank firmly · 35% evidence 46.5 out of 100 Growth Capital Valuation Relative 67. [63 Moons Technologies Ltd](https://www.sectoralpha.in/stocks/63-moons-technologies-ltd) 63MOONS · leader · Too little evidence to rank firmly · 46% evidence 45.6 out of 100 Growth Capital Valuation Relative 68. [XT Global Infotech Ltd](https://www.sectoralpha.in/stocks/xt-global-infotech-ltd) XTGLOBAL · Too little evidence to rank firmly · 40% evidence 45.4 out of 100 Growth Capital Valuation Relative 69. [IDream Film Infrastructure Company Ltd](https://www.sectoralpha.in/stocks/idream-film-infrastructure-company-ltd) quiet · Too little evidence to rank firmly · 42% evidence 34.9 out of 100 Growth Capital Valuation Relative Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [IT - Software](https://www.sectoralpha.in/sectors/it-software), all 69 compared on one page. ## Which companies are close to Capillary Technologies India in size? Capillary Technologies India is the 21st largest of 68 IT - Software companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: 63 Moons Technologies, AvenuesAI and Datamatics Global Services. Just below it: Cigniti Technologies, Aurionpro Solutions and R Systems International. ### IT - Software companies close in size 1. [63 Moons Technologies Ltd](https://www.sectoralpha.in/stocks/63-moons-technologies-ltd) ₹4,372 crore 2. [AvenuesAI Ltd](https://www.sectoralpha.in/stocks/avenuesai-ltd) ₹4,207 crore 3. [Datamatics Global Services Ltd](https://www.sectoralpha.in/stocks/datamatics-global-services-ltd) ₹4,163 crore 4. Capillary Technologies India Ltd ₹4,000 crore 5. [Cigniti Technologies Ltd](https://www.sectoralpha.in/stocks/cigniti-technologies-ltd) ₹3,472 crore 6. [Aurionpro Solutions Ltd](https://www.sectoralpha.in/stocks/aurionpro-solutions-ltd) ₹2,986 crore 7. [R Systems International Ltd](https://www.sectoralpha.in/stocks/r-systems-international-ltd) ₹2,972 crore [All 68 IT - Software companies, largest first](https://www.sectoralpha.in/sectors/it-software#all-companies) ### Companies close in size in other industries 1. [Shoppers Stop Ltd](https://www.sectoralpha.in/stocks/shoppers-stop-ltd) ₹4,008 crore · Retail - Departmental Stores 2. [TCPL Packaging Ltd](https://www.sectoralpha.in/stocks/tcpl-packaging-ltd) ₹4,005 crore · Packaging - FMCG/Consumers 3. Capillary Technologies India Ltd ₹4,000 crore 4. [Texmaco Rail & Engineering Ltd](https://www.sectoralpha.in/stocks/texmaco-rail-engineering-ltd) ₹3,998 crore · Railways 5. [Gujarat Alkalies & Chemicals Ltd](https://www.sectoralpha.in/stocks/gujarat-alkalies-chemicals-ltd) ₹3,975 crore · Chemicals - Inorganic - Caustic Soda/Soda Ash ## What else do people ask about Capillary Technologies India? ### What is Capillary Technologies India's share price today? Capillary Technologies India Ltd's share price is ₹510.10, −15.9% over the past year. The whole company is worth ₹4,056 Cr on the market. In the last 52 weeks it traded between ₹449 to ₹732; today it is 22% of the way up from the low, 5.5% below its 200-day average (as of 4 November 2026). ### What were Capillary Technologies India's latest quarterly results? Capillary Technologies India Ltd reported revenue of ₹257 Cr and a net loss of ₹9.6 Cr for the Jun 2026 quarter. Revenue rose 42.7% and profit fell 1,373.3% compared with a year earlier. Earnings per share were −₹1.20 (as of 4 November 2026). ### What is Capillary Technologies India's market cap? Capillary Technologies India Ltd's market capitalisation is ₹4,056 Cr at a share price of ₹510.10. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Capillary Technologies India performing? Capillary Technologies India Ltd's share price has been falling for 36 weeks. In its latest quarter, revenue rose 42.7% and profit fell 1,373.3% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 1 week running (as of 4 November 2026). ### Will Capillary Technologies India's share price go up? This page does not forecast Capillary Technologies India Ltd's share price. What it shows instead: the share price is ₹510.10, and it has been falling for 36 weeks. Its P/E of 79.2× is higher than 10% of its own last 1 years (as of 4 November 2026). ### Who owns Capillary Technologies India? Promoters own 47.2% of Capillary Technologies India Ltd, foreign institutions 2.6%, domestic institutions 21.9% and the public 28.3% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 4 November 2026). ### Does Capillary Technologies India have too much debt? No, Capillary Technologies India Ltd has little debt: its debt is 0.05× its equity, and its operating profit is 19 times its interest bill. FY26 borrowings were ₹54.0 Cr against equity of ₹1,024 Cr. So the returns on this page come from the business, not borrowed money (as of 4 November 2026). ### Where is Capillary Technologies India in its business cycle? Capillary Technologies India Ltd's FY26 operating margin was 13.0%, against a 6-year range of −23.0% to 13.0%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 15.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Capillary Technologies India story? The main question: yearly earnings per share moved +264.6% while the share price moved −15.9%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Capillary Technologies India a stock worth studying right now? What the numbers show: Capillary Technologies India Ltd's earnings have grown faster than its share price. Earnings per share grew +264.6% in a year while the price moved −15.9%. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ### Is there a Capillary Technologies India share price forecast for 2026? What management itself guided: FY27 revenue above ₹1,065 crore. ## Lists - IT stocks: https://www.sectoralpha.in/sectors/it-stocks-india This is research, not advice. We’re not SEBI-registered.